Cardiovascular
Eli Lilly and Company to Open a Diabetes-Focused Research Center in China
November 2, 2010 12:33 am | by Bio-Medicine.Org | News | CommentsINDIANAPOLIS, Nov. 2, 2010 /- Eli Lilly and Company (NYSE: LLY ) announced today plans to open a research center focused on diabetes in China, where the incidence of the disease has reached epidemic proportions. The center, to open in Shanghai in the second half of 2011, will focus on...
7,000 Bracelets For Hopeâ„¢ - A Rare Disease Awareness Campaign
November 1, 2010 3:33 am | by Bio-Medicine.Org | News | CommentsDANA POINT, Calif., Nov. 1, 2010 /PRNewswire-USNewswire/ -- The Global Genes Project ( www.globalgenesproject.org ), a non-profit advocacy organization that aims to raise awareness about the prevalence of rare diseases worldwide, today launched the 7,000 Bracelets for Hope™...
Lilly CEO: 'Are We Getting Our Money's Worth from Medical Innovation?'
October 29, 2010 9:33 am | by Bio-Medicine.Org | News | CommentsDALLAS, Oct. 29 /- In a speech to the Dallas Friday Group today, John C. Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company (NYSE: LLY ), said that the value of medical innovation – particularly innovative medicines – far outstrips its cost....
VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
October 29, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Oct. 29 /- See video from Roche Pharmaceuticals at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=23a45dd7-b... Roche announced on October 29 that the European Commission has...
FDA Approves Additional Medical Indication for Sprycel
October 28, 2010 11:33 am | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md., Oct. 28 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase...
Aethlon Medical Names Rod Kenley President
October 28, 2010 8:32 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Oct. 28 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has named Rod Kenley to be President of Aethlon Medical. Aethlon Chairman and CEO, Jim...
Gen-Probe to Webcast Two Upcoming Investor Presentations
October 27, 2010 6:32 pm | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Oct. 27 /- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at the Oppenheimer 21st Annual Healthcare Conference in New York on November 2, 2010 at 11:25 a.m. Eastern time, and at the Lazard Capital Markets 7th Annual Healthcare Conference in...
Advancements in Technology Benefit Cardiology Patients at Palos Community Hospital
October 27, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsPALOS HEIGHTS, Ill., Oct. 27 /PRNewswire-USNewswire/ -- Interventional cardiologists affiliated with Palos Community Hospital are among the first in Chicago's southwest suburbs to embrace the transradial approach for heart angiograms and clearing blocked arteries. Transradial...
PennDOT, State Police Caution Motorists About Dangers of Driving Under Influence of Legal Drugs
October 25, 2010 11:35 am | by Bio-Medicine.Org | News | CommentsHARRISBURG, Pa., Oct. 25 /PRNewswire-USNewswire/ -- PennDOT and the Pennsylvania State Police are reminding motorists that driving while under the influence of prescription and over-the-counter medication can be just as dangerous as driving under the influence of alcohol and illegal...
GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch'
October 25, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsLILLE, France and CAMBRIDGE, Mass., Oct. 25 /- GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today...
CryoLife Begins Distribution of Blood-Clotting Agent PerClot® in Europe
October 25, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsATLANTA, Oct. 25 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during...
Panasonic Makes Investment in Houston-based CardioNexus Corp.
October 25, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsSECAUCUS, N.J., Oct. 25 /- Panasonic Corporation of North America has completed an investment in CardioNexus Corporation, a portfolio company of Houston's Fairway Medical Technologies which works closely with the Texas Medical Center. The move is part of Panasonic's plans to establish...
10 Tips for Breast Cancer Survivors
October 22, 2010 9:32 am | by Bio-Medicine.Org | News | CommentsSEATTLE, Oct. 22 /- Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering weekly research-based tip sheets regarding breast cancer prevention, screening...
Social interaction can identify mental pathology
October 22, 2010 7:32 am | by Baylor College of Medicine | News | CommentsIf your doctor thinks your blood pressure is too high, she can measure it with an instrument. If she thinks you are anemic, she can order a lab test. Psychiatrists seeking to identify mental disorders must depend on less precise measures – observations of behaviors and various...
Children's Hospital granted $3M to study rare blood disease
October 22, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | News | CommentsChildren’s Hospital Boston has received a $3.9 million grant from the National Institutes of Health to work on a treatment on a fatal genetic blood disease called Fanconi anemia.
Thoratec Schedules Third Quarter Conference Call, Webcast
October 22, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsPLEASANTON, Calif., Oct. 22 /- Thoratec Corporation (Nasdaq: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the third quarter and first nine months...
New Label Changes for Commonly Prescribed HIV Drug Invirase
October 21, 2010 12:32 pm | by Bio-Medicine.Org | News | CommentsSILVER SPRING, Md., Oct. 21 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening side effects on the heart when...
DNA minivectors provide new gene therapy tool
October 21, 2010 3:33 am | by Baylor College of Medicine | News | CommentsTiny wound-up circular bits of DNA that carry a short "hairpin" of RNA could prove a solution to the quest for a non-toxic, long-lived gene therapy vector designed to silence cancer genes in tumor cells, said researchers from Baylor College of Medicine and The Methodist Hospital Research...
FDA approves Boehringer Ingelheim blood clot treatment
October 20, 2010 5:33 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsThe U.S. Food and Drug Administration has approved Pradaxa, a drug developed by Boehringer Ingelheim Corp. to lower the risk of stroke and blood clots in patients with irregular heartbeats.
Beaumont Hospital Opens New Ernst Cardiovascular Center
October 20, 2010 6:34 am | by Bio-Medicine.Org | News | CommentsROYAL OAK, Mich., Oct. 20 /- Beaumont Hospitals' world renowned heart center has expanded and enhanced its services with the Oct. 18 opening of the new Ernst Cardiovascular Center at Beaumont Hospital, Royal Oak. Specialty clinics in the new Ernst Cardiovascular Center offer breakthrough...
Patient Experience Research Grants Awarded
October 19, 2010 11:31 am | by Bio-Medicine.Org | News | CommentsDALLAS, Oct. 19 /- As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues. (Logo:...
MultiCell's Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
October 19, 2010 7:33 am | by Bio-Medicine.Org | News | CommentsWOONSOCKET, R.I., Oct. 19 /- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET ) and its majority owned subsidiary, Xenogenics Corporation, are pleased to announce the acquisition of the Ideal™ BioStent assets by Xenogenics Corporation from investment funds managed by Western...
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
October 19, 2010 7:32 am | by Bio-Medicine.Org | News | CommentsSAN DIEGO, Oct. 19 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that Rod Kenley has been appointed to the Aethlon Medical board of directors. (Photo:...
UT Southwestern Doctor's Expertise Helped Trapped Chilean Miners During Pressured Half-Mile-Deep Rescue(2)
October 18, 2010 4:33 pm | by Bio-Medicine.Org | News | CommentsDALLAS, Oct. 18 /PRNewswire-USNewswire/ -- When rescuers needed to determine how to safely extract Chilean miners without their fainting and suffering a potentially devastating loss of blood to the brain, they turned to a UT Southwestern Medical Center scientist whose expertise typically...
Reportlinker Adds Global Minimally Invasive Surgery Market.(2010 - 2015)
October 18, 2010 3:33 pm | by Bio-Medicine.Org | News | CommentsNEW YORK, Oct. 18 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Minimally Invasive Surgery Market.(2010 - 2015) http://www.reportlinker.com/p0316089/Global-Minimally-Invasive-Surgery-M... Global Minimally Invasive...
